SHEPHERD KAPLAN KROCHUK, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 93 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHEPHERD KAPLAN KROCHUK, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$229,000
+114.0%
49,7610.0%0.19%
+206.5%
Q2 2017$107,000
-31.8%
49,7610.0%0.06%
-23.5%
Q1 2017$157,000
+21.7%
49,7610.0%0.08%
+118.9%
Q4 2016$129,000
-74.0%
49,761
-61.1%
0.04%
-64.1%
Q3 2016$497,000
+44.5%
127,8460.0%0.10%
+19.8%
Q2 2016$344,000
-12.7%
127,8460.0%0.09%
-29.5%
Q1 2016$394,000
+34.0%
127,846
+67.2%
0.12%
+56.4%
Q4 2015$294,000
+26.2%
76,4720.0%0.08%
+25.8%
Q3 2015$233,000
-43.9%
76,472
-28.8%
0.06%
-15.1%
Q1 2015$415,000
-71.3%
107,392
-50.0%
0.07%
-68.5%
Q4 2014$1,445,000
+22.6%
214,7840.0%0.23%
+53.6%
Q3 2014$1,179,000
-2.8%
214,784
+81.4%
0.15%
+17.1%
Q2 2014$1,213,000
-26.0%
118,390
-13.2%
0.13%
-31.7%
Q1 2014$1,639,000
+6.2%
136,4690.0%0.19%
-3.1%
Q4 2013$1,543,000
+7.1%
136,469
+2.1%
0.20%
-16.3%
Q3 2013$1,441,000
-17.5%
133,670
-29.0%
0.23%
-32.3%
Q2 2013$1,746,000188,3370.34%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Kovack Advisors, Inc. 24,393$82,0000.02%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders